Literature DB >> 22527230

A short scale for evaluation of neuropsychiatric disorders in Parkinson's disease: first psychometric approach.

Pablo Martinez-Martin1, Belen Frades-Payo, Luis Agüera-Ortiz, Angel Ayuga-Martinez.   

Abstract

The neuropsychiatric symptoms and behavioral disorders affecting Parkinson's disease (PD) patients are common and disabling. A PD-specific interview-based 12-item scale, the Scale for Evaluation of Neuropsychiatric Disorders in Parkinson's Disease (SEND-PD), has been developed to assess the severity of neuropsychiatric manifestations. The present study is aimed at testing some basic psychometric attributes of this scale. A total of 633 consecutive patients and their caregivers were included in this cross-sectional, multicenter, observational study. In addition to the tested scale, the following assessments were applied: Hoehn and Yahr staging, Scales for Outcomes in Parkinson's Disease Motor and Psychiatric complications, MiniMental State Examination, Clinical Impression of Severity Index, and the Zarit Caregiver Burden Inventory. Patients in all stages of disease were included and 18.38 % were demented. The SEND-PD was responded by patients (86.16 %), caregivers (13.15 %), or both (0.69 %). Three factors (accounting for 66.63 % of the variance) were identified and considered as subscales: Psychotic symptoms, Mood/Apathy, and Impulse control disorders. The subscales showed satisfactory scaling assumptions (multitrait-item success rate 100 %) and internal consistency (alpha indices >0.70). The convergent validity with other measures of psychiatric symptoms and the discriminant validity to distinguish between categories of patients' age, duration and severity of disease, and dopaminergic treatment were satisfactory. The precision of the scale dimensions was acceptable. The SEND-PD performed as an acceptable, consistent, valid, and precise scale for evaluation of neuropsychiatric symptoms in Parkinson's disease.

Entities:  

Mesh:

Year:  2012        PMID: 22527230     DOI: 10.1007/s00415-012-6490-x

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  61 in total

1.  Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients.

Authors:  Daniel Weintraub; Juergen Koester; Marc N Potenza; Andrew D Siderowf; Mark Stacy; Valerie Voon; Jacqueline Whetteckey; Glen R Wunderlich; Anthony E Lang
Journal:  Arch Neurol       Date:  2010-05

2.  Double-blind, placebo-controlled, unforced titration parallel trial of quetiapine for dopaminergic-induced hallucinations in Parkinson's disease.

Authors:  William G Ondo; Ron Tintner; Kevin Dat Voung; Dejian Lai; George Ringholz
Journal:  Mov Disord       Date:  2005-08       Impact factor: 10.338

3.  Dementia associated with Parkinson's disease: applying the Movement Disorder Society Task Force criteria.

Authors:  P Martinez-Martin; C Falup-Pecurariu; C Rodriguez-Blazquez; M Serrano-Dueñas; F J Carod Artal; J M Rojo Abuin; D Aarsland
Journal:  Parkinsonism Relat Disord       Date:  2011-06-30       Impact factor: 4.891

4.  Prevalence of psychotic symptoms in a community-based Parkinson disease sample.

Authors:  Joel Mack; Peter Rabins; Karen Anderson; Susanne Goldstein; Stephen Grill; Elaina S Hirsch; Susan Lehmann; John T Little; Russell L Margolis; Justin Palanci; Gregory Pontone; Howard Weiss; James R Williams; Laura Marsh
Journal:  Am J Geriatr Psychiatry       Date:  2012-02       Impact factor: 4.105

Review 5.  Psychometric considerations in evaluating health-related quality of life measures.

Authors:  R D Hays; R Anderson; D Revicki
Journal:  Qual Life Res       Date:  1993-12       Impact factor: 4.147

6.  Parkinsonism: onset, progression and mortality.

Authors:  M M Hoehn; M D Yahr
Journal:  Neurology       Date:  1967-05       Impact factor: 9.910

7.  Quality of life in patients with Parkinson's disease: development of a questionnaire.

Authors:  A G de Boer; W Wijker; J D Speelman; J C de Haes
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-07       Impact factor: 10.154

8.  [Neuropsychological disorders in Parkinson's disease: evaluating them and their impact on the caregiver].

Authors:  P Martínez-Martín; M T Guerrero-Díaz; B Frades-Payo
Journal:  Rev Neurol       Date:  2004 Oct 1-15       Impact factor: 0.870

9.  The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia.

Authors:  J L Cummings; M Mega; K Gray; S Rosenberg-Thompson; D A Carusi; J Gornbein
Journal:  Neurology       Date:  1994-12       Impact factor: 9.910

10.  Cross-cultural evaluation of the modified Parkinson Psychosis Rating Scale across disease stages.

Authors:  Javier Virués-Ortega; Carmen Rodríguez-Blázquez; Federico Micheli; Francisco Javier Carod-Artal; Marcos Serrano-Dueñas; Pablo Martínez-Martín
Journal:  Mov Disord       Date:  2010-07-30       Impact factor: 10.338

View more
  6 in total

1.  Validation of the multimodal assessment of capacities in severe dementia: a novel cognitive and functional scale for use in severe dementia.

Authors:  Sloane Heller; Carolina Mendoza Rebolledo; Carmen Rodríguez Blázquez; Laura Carrasco Chillón; Almudena Pérez Muñoz; Irene Rodríguez Pérez; Pablo Martínez-Martín
Journal:  J Neurol       Date:  2015-03-06       Impact factor: 4.849

2.  Improvement of impulse control disorders associated with levodopa-carbidopa intestinal gel treatment in advanced Parkinson's disease.

Authors:  Maria Jose Catalan; Jose Antonio Molina-Arjona; Pablo Mir; Esther Cubo; Jose Matias Arbelo; Pablo Martinez-Martin
Journal:  J Neurol       Date:  2018-03-20       Impact factor: 4.849

3.  A clinical profile of patients with Parkinson's disease and psychosis.

Authors:  B R Amar; Ravi Yadav; Y C Janardhan Reddy; Pramod Kumar Pal
Journal:  Ann Indian Acad Neurol       Date:  2014-04       Impact factor: 1.383

4.  Independent Validation of the SEND-PD and Correlation with the MDS-UPDRS Part IA.

Authors:  Mayela Rodríguez-Violante; Amin Cervantes-Arriaga; Salvador Velázquez-Osuna; Rodrigo Llorens-Arenas; Humberto Calderón-Fajardo; Dan Piña-Fuentes; Pablo Martinez-Martin
Journal:  Parkinsons Dis       Date:  2014-10-23

5.  Validation of the English Version of the Multimodal Assessment of Capacities in Severe Dementia (MAC-SD): A Cognitive and Functional Scale for Use in Severe Dementia.

Authors:  Sloane Heller; Alan Steinberg; Mark Sedler
Journal:  J Alzheimers Dis Rep       Date:  2017-12-16

6.  Neuropsychiatric Symptoms in Parkinson's Disease Patients Are Associated with Reduced Health-Related Quality of Life and Increased Caregiver Burden.

Authors:  Hannah von Eichel; Johanne Heine; Florian Wegner; Sophia Rogozinski; Stephanie Stiel; Adrian Groh; Lea Krey; Günter U Höglinger; Martin Klietz
Journal:  Brain Sci       Date:  2022-01-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.